A more important finding was observed that peritumoral HSCs served as unfavorable prognostic predictors in several subgroups including early recurrence group (≤ 24 months) [15] and AFP-normal patients in HBV related HCC. This evidence concerns the gene AFP and hepatocellular carcinoma.